Protagenic Therapeutics, Inc.

Historical 13F Holders

Symbol
PTIX
CUSIP
74365N202
All holders as of
Q1 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 74365N202 since 12/18/2024, newest first.

Filer % of Class Filed
Bigger Capital Fund L P 13G/A Amendment 1
0% 8/25/2025
Event 8/22/2025
Bigger Capital Fund L P 13G
5.8% 7/8/2025
Event 7/2/2025
Armistice Capital, LLC 13G/A Amendment 4
3.4% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 10 338 k $65.9 k
2024 Q4 10 150 k $75.0 k
2024 Q3 12 165 k $104 k
2024 Q2 13 160 k $146 k
2024 Q1 14 537 k $12.1 M
2023 Q4 12 113 k $107 k
2023 Q3 10 96.4 k $144 k
2023 Q2 11 97.2 k $198 k
2023 Q1 10 95.4 k $164 k